BioNTech To Open First Vaccine Hub In Rwanda

The German firm, BioNTech, has signed deals with Rwanda and Senegal to build Africa’s first vaccine manufacturing facility based on mRNA technology.<br />BioNTech says the plant will have an initial capacity to produce 50 million doses annually. The plant will be built in Rwanda.<br />The partners say mRNA vaccines could also be developed to fight other diseases such as malaria and tuberculosis.<br />Rwanda’s Health Minister Daniel Ngamije said the goal was to include Africa in networks of scientific innovation and production.